美股市场个股详情
TCDAQ TRICIDA INC
- 0.000010
- 0.0000000.00%
延时15分钟行情收盘价 08/13 16:00 (美东)
580.28总市值0.00市盈率TTM
0.000000最高价0.000000最低价0股成交量0.000000今开0.000010昨收0.00成交额0.00%换手率0.00市盈率(静)5802.83万总股本0.00001052周最高0.00市净率335.93流通值0.00001052周最低--股息TTM3359.29万流通股44.300000历史最高--股息率TTM0.00%振幅0.000010历史最低--平均价1股每手
关于TRICIDA INC公司
Tricida Inc是一家制药公司。 它专注于其候选药物veverimer（TRC101）的开发和商业化，veverimer（TRC101）是一种非吸收性，口服给药的聚合物，旨在通过结合和去除胃肠道或胃肠道中的酸来治疗代谢性酸中毒。 关注的主要领域是通过代谢性酸中毒的治疗来减缓慢性肾脏疾病的进展。
公司介绍
董事高管
- 姓名
- 职务
- 年薪
- Dr. Gerrit Klaerner, PhD.
- Director, President and Chief Executive Officer
- --
- Geoffrey M. Parker
- Chief Operating Officer, Chief Financial Officer and Executive Vice President
- --
- Robert McKague
- Executive Vice President, General Counsel and Chief Compliance Officer
- --
- Annie Yoshiyama
- Vice President, Finance and Chief Accounting Officer
- --
- Dr. Dawn Parsell
- Executive Vice President, Clinical Development
- --
- Dr. Klaus Veitinger, M.D.,PhD
- Chairman of the Board
- --
- Dr. David P. Bonita, M.D.
- Independent Director
- --
- Dr. David Hirsch, M.D.,PhD
- Independent Director
- --
- Dr. Robert J. Alpern,M.D.
- Independent Director
- --
- Thomas G. FitzGerald
- Independent Director
- --
- Sandra I Coufal
- Independent Director
- --
- Kathryn E. Falberg
- Independent Director
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据